CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

FRONTIER CAPITAL MANAGEMENT CO LLC's Holding History (CIK: 0000351173)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 53,277 Value ($000) $2,877 Avg Close $57.84 Range $51.02 - $68.39
Q1 2024
Shares 102,098 Value ($000) $6,959 Avg Close $71.59 Range $58.29 - $91.10
Q4 2023
Shares 254,972 Value ($000) $15,961 Avg Close $55.02 Range $37.55 - $76.97
Q3 2023
Shares 265,135 Value ($000) $12,034 Avg Close $51.65 Range $44.53 - $59.67
Q2 2023
Shares 375,788 Value ($000) $21,097 Avg Close $56.74 Range $43.10 - $72.00
Q1 2023
Shares 46,347 Value ($000) $2,096 Avg Close $48.57 Range $39.88 - $58.50
Q4 2022
Shares 55,871 Value ($000) $2,271 Avg Close $53.05 Range $38.94 - $66.31
Q3 2022
Shares 318,910 Value ($000) $20,841 Avg Close $72.47 Range $60.41 - $86.95
Q2 2022
Shares 168,485 Value ($000) $10,239 Avg Close $58.79 Range $42.51 - $75.42
Q1 2022
Shares 147,917 Value ($000) $9,285 Avg Close $62.79 Range $50.54 - $79.40
Q4 2020
Shares 3,186 Value ($000) $488 Avg Close $118.20 Range $79.31 - $181.42
Q3 2020
Shares 3,187 Value ($000) $267 Avg Close $88.70 Range $74.00 - $105.12
Q2 2020
Shares 159,458 Value ($000) $11,719 Avg Close $58.47 Range $38.10 - $79.92
Q1 2020
Shares 115,112 Value ($000) $4,882 Avg Close $51.63 Range $32.30 - $64.19
Q4 2019
Shares 76,636 Value ($000) $4,668 Avg Close $54.60 Range $35.46 - $74.00
Q2 2018
Shares 54,631 Value ($000) $3,210 Avg Close $56.97 Range $40.25 - $73.90